Brilliant analysis Pharma;
I would rather be invested in a company with an under valued share price with real products + real science + real revenue + real potential + real deals than...
one with overly inflated share price with no revenue + no guidance + pure speculation + high cash burn + awaiting drill results + cyclical sentiment